Metacrine lays off half its staff, mainly researchers, and ditches more work to focus on IBD after NASH disaster

Metacrine lays off half its staff, mainly researchers, and ditches more work to focus on IBD after NASH disaster

Submitted by admin on February 12, 2022 - 11:52pm
Source: 
Fierce Biotech
News Tags: 
Metacrine
layoffs
NASH
Headline: 
Metacrine lays off half its staff, mainly researchers, and ditches more work to focus on IBD after NASH disaster
snippet: 

The 2021 NASH disaster at Metacrine has extended into 2022. The company has fired half its staff and ended work on a preclinical asset intended for the fatty liver disease.

Do Not Allow Advertisers to Use My Personal information